Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS207 in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07690787Phase 2Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of JS207 in nasopharyngeal carcinoma (NPC), sponsored by The Chinese University of Hong Kong. Started Jun 2026; status: recruiting.
02
Drugs
JS207
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT07690787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07690787.